MUMBAI, India, Dec. 22, 2025 /PRNewswire/ -- The ASSOCHAM D&B Small Business Confidence Index for the Oct-Dec 2025 quarter stands at…
First-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo’s proprietary cancer prodrugs December 17, 2025 10:10 ET |…
10 December 2025 - The International Olympic Committee’s (IOC’s) Executive Board (EB) has invited Asunción Paraguay; Bangkok, Thailand; and Santiago, Chile into a…
Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a decentralized finance (DeFi) project focused on lending and…
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm…
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results selected as one of only 10 featured presentations…
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering November 24, 2025…
MUMBAI, India, Nov. 24, 2025 /PRNewswire/ -- The Foundation for Advancement of Micro Enterprises (FAME), a 'not-for-profit company' has strengthened the…
November 21, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”,…